AzTrials
AzTrials

Smoking CessationNCT05430529

Alcohol Control in Smoking Cessation

A study testing Standard Smoke Cessation Service and Brief Alcohol Intervention for Intervention Group in people with Smoking Cessation, run by The University of Hong Kong at 1 site in Hong Kong.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study aims to develop a theory-driven, brief alcohol intervention protocol for HCPs to deliver the intervention for co-users of tobacco and alcohol during smoking cessation treatment. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Smoking Cessation
What is being tested?
Standard Smoke Cessation Service and Brief Alcohol Intervention for Intervention Group
Could I receive a placebo?
No, everyone receives an active treatment
How many people
100 participants
Where
1 siteHong Kong
Study dates
17 Jun 2022to 31 Oct 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Self-report tobacco use in the past month
  • Aged 18 or above
  • Currently using or recently enrolled in local smoking cessation service
  • Able to communicate in Cantonese/Mandarin and read Chinese
  • Self-report alcohol use in either of the four drinking levels:
  • Lower-risk of drinking problems (AUDIT score 1-7)
Show all 15Show fewer
  • Drinking at increasing risk (AUDIT score 8-15)
  • Harmful drinking (AUDIT score 16-19)
  • Having drinking dependence (AUDIT score >=20)
  • Self-report one of the following:
  • In previous quit attempts in lifetime, have smoked few cigarettes due to drinking alcohol (but not relapse)
  • In the past 3 months, have felt an urge to smoking during/ after drinking
  • In the past 3 months, smoked when drinking
  • Smoked more cigarettes when drinking, compared to the day of smoke only
  • In general, the drinking habit influenced the motivation to quit smoking

Who cannot join

None listed.

Trial locations and contacts

1 site in 1 country.

Hong Kong1 site
  • Tung Wah Group of Hospitals Integrated Centre on Smoking Cessation

    Hong Kong

Other trials in Hong Kong

About this study

Official title: Development and a Pilot Randomized Controlled Trial of a Brief Alcohol Intervention During Smoking Cessation Treatment Delivered by Healthcare Professionals

This study aims to develop a theory-driven, brief alcohol intervention protocol for HCPs to deliver the intervention for co-users of tobacco and alcohol during smoking cessation treatment. The primary hypothesis is that smoking cessation treatment including the alcohol intervention will increase tobacco abstinence and reduce alcohol drinking. Our second hypothesis is that the brief intervention to deal with alcohol use will be feasible during smoking cessation treatment and be widely accepted by smokers.

Read the detailed description

Co-use of Alcohol and Tobacco Co-use of tobacco and alcohol is common globally. Positive association of smoking and drinking at individual level has been found in both community settings and psychiatric epidemiological studies. In the U.S (2001-2002), about 21.7% of current drinkers were also current smokers, and about 34.8% of current smokers were current drinkers. In Hong Kong, according to the population-based study conducted by Hong Kong Council on Smoking and Health in 2018, about 22.2% and 9.3% of current smokers drank at least once a week and drank alcohol daily, respectively. From the client data (2014-16) of Tung Wah Group of Hospitals Integrated Centre on Smoking Cessation (TWGH-ICSC), the largest cessation service provider in Hong Kong, the prevalence of lower-risk drinking, increasing risk drinking, harmful drinking, and probable alcohol dependence, screened by the Alcohol Use Disorders Identification Test (AUDIT). in their clients is about 46.7%, 10.9%, 2.7% and 2.4%, respectively.

Co-use of tobacco and alcohol is harmful and incur substantial economic loss. Both tobacco and alcohol were classified by World Health Organization (WHO) as a Group 1 carcinogens. Concurrent use of tobacco and alcohol leads to 25.3% mortality due to coronary heart disease, stroke, respiratory and smoking-related cancer, compared with 20.5% among people who only smoked and 12.8% among who only had 15+ units of alcohol each week. Co-use of alcohol and tobacco also poses a severe economic burden on family and community. According to the Lancet's 2017 study, tobacco use costs global economies more than US$1 trillion annually through loss of productivity and health-care expenditure, while the weighted average cost of alcohol consumption ranged from 0.45 and 5.44% of Gross domestic Product (GDP)purchasing power parity (PPP) globally.

How Alcohol Use Hinders Smoking Cessation Alcohol consumption hinders smoking cessation, which can be explained by the theory in subjective reward effects, cross-substance cue reactivity, and other psychosocial factors. Based on the subjective reward effects, alcohol consumption increases nicotine's subjective rewarding effects, and hence increases satisfaction, liking, and calming feelings due to nicotine. Therefore, attempts to quit smoking are less successful among those with alcohol use disorder. The cross-substance cue reactivity suggested that there are cognitive or semantic associations between alcohol and cigarette use. That is, one substance will cue the use of the other substance. When alcohol and tobacco are used together for a number of times, the use of either substance will trigger a craving of another substance. This theory was commonly used to explain why alcohol is always an obstacle in smoking cessation and a cue for smoking relapse. These mechanisms have been supported by intervention trials and observational studies, showing that smoking rates among drinkers of different levels were significantly higher compared with non-drinkers after receiving smoking cessation treatment. If health care professionals (HCPs) do not handle smokers' drinking problems, they may miss the opportunity to help smokers to tackle the drinking problems at the same time.

Local Findings From the 2014-16 record of TWGH-ICSC, the self-reported quit rate at 26-week for clients with baseline AUDIT score 1-8, 9-15, and ≥16 after receiving the standard smoking cessation treatment was 43.4% (95% Confidence Interval (CI) 41.8%-45.1%), 37.1% (95%CI 33.8%-40.5%) and 26.7% (95%CI 22.4%-31.4%), respectively. The 52-week quit rate in these three drinking groups showed similar contrast (AUDIT score 1-8: 38.7%, 95%CI 37.0%-40.3%; 9-15: 31.9%, 95%CI 28.7%-35.2%; ≥16: 21.6%, 95%CI 17.7%-26.1%). Therefore, higher alcohol dependence is associated with lower abstinence in quit attempters who receive smoking cessation treatment. Two participants who self-reported tobacco abstinence for over a month from our ongoing qualitative study (funded by Health and Medical Research Fund (HMRF), ref no. 15163001) of smoking cessation stated that they were only smoking when they were drinking alcohol. They expressed that they smoked whenever they were drinking with friends and did not perceive occasional smoking during drinking episode as smoking relapse. All these results suggested that alcohol use reduces the effectiveness of smoking cessation treatment.

Interventions for Smoking and Drinking Co-use The above literature review suggested that a smoking cessation treatment that simultaneously addresses both alcohol and smoking problems is needed in clinical practice. The U.S. clinical practice guideline of treating tobacco use and dependence mentioned that helping smokers to recognize the dangerous situations of alcohol use is essential, and HCPs should instruct smokers to reduce/abstain from alcohol while quitting smoking. Previous study in alcohol treatment showed that alcohol users generally accept a concurrent treatment of both smoking cessation and alcohol.Combination of pharmacotherapy (i.e. varenicline and naltrexone) has been recommended to effectively and simultaneously treat heavy alcohol use and nicotine dependence.

Evidence-based brief intervention for reducing alcohol use has been established and is recommended by WHO. Behavioral interventions included personalized feedback, decisional balance, quit day setting and tailored skills-building. However, the effectiveness of these behavioral intervention for increasing tobacco abstinence and reducing alcohol use across the intervention trials is inconsistent. The investigators found 3 randomized controlled trials (RCTs) showed a promising effect of the intervention in increasing tobacco abstinence, but other 2 RCTs did not or even reduce tobacco abstinence rate. To late, there has been no systematic review on the effect of incorporating alcohol intervention into smoking cessation treatment. Therefore, the evidence is not yet conclusive.

Local Services for Alcohol Intervention Hospital Authority and non-governmental organizations are providing alcohol treatments, including Hospital Authority's Psychiatry Specialist Out-patient Clinics (SOPCs), Tung Wah Group of Hospitals Integrated Centre for Addiction Prevention and Treatment (ICAPT), TWGH's Alcohol Abuse Prevention and Treatment Service--"Stay Sober, Stay Free," and Alcoholics Anonymous Hong Kong. There has been no publication and data on the utilization of these services.

The Department of Health promoted screening and subsequently delivering a tailored health advice for alcohol users with AUDIT. It published a guide for HCPs to assess drinking and deliver an AUDIT-based brief alcohol intervention in primary health setting in 5-10 minutes. The first three questions of the AUDIT are grouped as AUDIT-C version, which attempts to quickly screen drinkers with high alcohol consumption level. If patients score 3 or above in AUDIT-C, HCPs will proceed to assess alcohol dependence with the rest of the AUDIT. The 3-rd question of the AUDIT-C ("How often do participants have at least 5 cans of beer/5 glasses of table wine/5 peg of spirits on one occasion?) is an indicator of binge-drinking.

According to the local guide on using AUDIT-based intervention, patients with lower-risk drinking (score 1-7in the AUDIT) should receive advice on health risks of drinking and they should drink less or abstain from alcohol. Patients with an increasing risk of drinking (score 8-15 in the AUDIT) should be warned on the increasing risk and impairment due to drinking, and they should cut down drinking. Patients with harmful drinking (score 16-19 in the AUDIT) usually have a pattern of alcohol use that is causing damage to health, hence they should receive a more severe warning and be encouraged to seek professional support. Patients who are defined as probable dependence (score 20 or above in the AUDIT) showed a cluster of behavioral, cognitive, and physiological phenomena, such as strong desire to consume alcohol, impaired self-control, persistent drinking, and physical withdrawal reaction). The HCPs should let them know that drinking is already causing alcohol dependence, and advise the patients to stop or reduce drinking under the help of professionals. It's best to refer patients in this category to a specialist for more in-depth evaluation and treatment. In addition to the above framework, pregnant women, persons on medication and persons with mental illnesses should be asked to abstain completely from alcohol.

Although this brief guide includes the instruction to educate drinkers the risks of excessive alcohol use and refer other services, there are several implementation difficulties. The guide was solely developed for alcohol reduction/abstinence, but it does not involve the intervention for alcohol and tobacco co-use. This guide does not address alcohol use as a barrier of quitting smoking. It does not instruct HCPs on aspects of beliefs, attitude and more personalized advice for smokers. The effectiveness and feasibility in adapting this AUDIT-based in clinical setting has not been evaluated. To address these limitations, an AUDIT-based brief alcohol intervention that can be specifically incorporated in smoking cessation treatment is needed. An alcohol intervention protocol customized for co-users, and training for HCPs about the knowledge, attitude, and practice of delivering alcohol and tobacco intervention are needed.

Proposed Alcohol Intervention In the proposed intervention, AUDIT will be tentatively adopted to screen potential participants. A need assessment will be done to guide the adaptation and revision of the final protocol. To increase the feasibility of applying the alcohol intervention, the need assessment is required to understand (1) current routine in smoking cessation treatment; (2) HCPs' capacity (knowledge, attitudes and practice) and acceptability of the intervention; (3) current co-users' expectations and acceptability of the intervention.

The aforementioned framework in delivering personalized advice to drinkers with lower-risk, drinking at increasing risk, harmful drinking and drinking dependence will be used. Co-users of tobacco and alcohol should be advised the importance of quitting smoking and reducing/abstaining alcohol. The investigators propose a short and brief interventions for co-users who are receiving smoking cessation treatment, because the investigators believe their primary goal is smoking cessation. The co-users may not have enough time or readiness to discuss the issue of drinking problems intensively. A brief advice on drinking may be more acceptable than an intensive intervention for these smokers.

The alcohol intervention protocol will be guided by the theory of self-determination and general health promotion action. The self-determination theory values the importance of internalized autonomy rather than external factors (e.g., requests from family members, friends, or healthcare professionals) during behavioral regulation. Previous RCT had revealed that participants who had the option to decide on their treatment showed a higher level of compliance with instructions. The positive association between autonomy and competence has also been shown by our previous RCT on smoking cessation. Compared with people with less autonomy in treatment, people with greater independence reported greater competence in achieving behavioral change.

The investigators' general health promotion action (GHPA) model stated that people with general intention to promote health are more likely to adopt specific health promotion actions. Specifically, smokers who have general intention to promote health are more likely to stop smoking. If co-users have the intention to improve health, they may pursue both alcohol reduction/abstinence and smoking cessation. One intervention RCT found that smokers who initiated a quit attempt could reduce alcohol consumption by 2.3 units per week after the target quit day, and heavier drinking smokers presented a more significant decrease (6.1 units) in alcohol intake. Based on this model, our proposed study shall encourage the HCPs to increase participants' awareness and intention for health and a healthy lifestyle.

Aims and Hypotheses to be Tested:

This study aims to develop a theory-driven, brief alcohol intervention protocol for HCPs to deliver the intervention for co-users of tobacco and alcohol during smoking cessation treatment. The primary hypothesis is that smoking cessation treatment including the alcohol intervention will increase tobacco abstinence and reduce alcohol drinking. Our second hypothesis is that the brief intervention to deal with alcohol use will be feasible during smoking cessation treatment and be widely accepted by smokers.

Setting The recruitment sites will be the smoking cessation clinics or services under TWGH-ICSC in Hong Kong, which offer behavioral and/or pharmacological interventions. The TWGH-ICSC operates 5 service centers, serving around 3000 smokers each year. The investigators have successful experience of collaborating with these service providers in recruiting smokers for several projects. For example, the investigators recruited around 1,000 smokers from these service providers in an HMRF-funded project in 2018-2019 (Project No. 15163001).

Procedures The HCPs who deliver the smoking cessation counselling will screen the eligibility of the clients at the first or later follow-up of their smoking cessation treatment, and invite eligible participants to join the RCT. When a counselor identifies a potential client, he/she will briefly introduce the alcohol control program. Participants who agree to join the RCT will be required to sign the consent form. HCPs will then randomize the client to either the intervention group or control group afterwards. In the intervention group, participants will receive the standard smoke cessation service and personalized advice on alcohol control. The details and key components of the intervention will be addressed in the intervention section below. In the control group, HCPs will deliver the standard smoke cessation service that same as the usual practice.

Randomization, Blinding The Qualtrics (an online platform for collecting data) randomizer function will be used for the randomization (with 1:1 allocation ratio) in this study. After participants consent to the study, HCPs will access Qualtrics for randomization. The Qualtrics will display the group allocation (either intervention group or control group) after HCPs enter the participants' names. HCPs will inform participants regarding their group allocation immediately. All HCPs and the participants will not be blinded to the given interventions. Outcome assessors at the telephone follow-up are blinded to the group allocation.

Being tested
Standard Smoke Cessation Service, Short Advice for Control Group, Brief Alcohol Intervention for Intervention Group
Keywords
Alcohol Control, Intervention, Smoking Cessation, WhatsApp
Medical subject headings
Smoking Cessation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Standard Smoke Cessation ServiceBehavioural

    Both of the intervention group and control group will receive standard smoke cessation service, which is same as usual practice.

  • Short Advice for Control GroupBehavioural

    If the control group participant encountering difficulties in smoke cessation caused by alcohol usage, HCP will provide short advice to them. Participant will be urged not to drink during smoke quitting. If drinking is unavoidable, participant should not drink exceed the low-risk drinking portion recommended by Department of Health, which is 2 standard alcohol units for men and 1 stand alcohol unit for women per day. HCPs will remind participants to aware their drinking portion, in order to quit smoke successfully.

  • Brief Alcohol Intervention for Intervention GroupBehavioural

    During the face-to-face smoking cessation counseling session, HCPs will first play a 2 - 3 minutes short video with electronic devices to participants who are allocated to the intervention group.

    After the short video, HCPs will ask participants to share their thoughts and willingness of alcohol control. Participants are expected to show 4 responses: (1) refuse to attempt alcohol control; agree to attempt alcohol control that (2) quit drinking totally, (3) quit drinking for 2 weeks, or (4) reduce the alcohol consumption. HCPs will deliver personalized advice according to participants' choices and encourage them to receive the WhatsApp message reminders.

    In all participants, HCPs will invite them to receive WhatsApp messages reminders for incoming 4 weeks (3 messages per week).

    In addition, HCPs can choose to discuss with participants the reasons for consuming alcohol.

    Nevertheless, HCPs can also choose to provide AUDIT-based brief intervention to the participants.

Study groups in NCT05430529
Study groupRoleWhat they receive
Brief Alcohol Intervention for Intervention GroupExperimentalDuring the face-to-face smoking cessation counseling session, HCPs will first play a 2 - 3 minutes short video with electronic devices to participants who are allocated to intervention group. After the short video, HCPs will ask participants to share their thoughts and willingness of alcohol control. Participants are expected to show 4 responses: (1) refuse to attempt alcohol control; agree to attempt alcohol control that (2) quit drinking totally, (3) quit drinking for 2 weeks, or (4) reduce the alcohol consumption. HCPs will deliver personalized advice according to participants' choices and encourage them to receive the WhatsApp message reminders. In all participants, HCPs will invite them to receive WhatsApp messages reminders for incoming 4 weeks (3 messages per week). Nevertheless, HCPs can also choose to provide AUDIT-based brief intervention to the participants.
Receives: Behavioral: Standard Smoke Cessation Service; Behavioral: Brief Alcohol Intervention for Intervention Group
Short Advice for Control GroupActive comparatorIf the control group participant encountering difficulties in smoke cessation caused by alcohol usage, HCP will provide short advice to them. Participant will be urged not to drink during smoke quitting. If drinking is unavoidable, participant should not drink exceed the low-risk drinking portion recommended by Department of Health, which is 2 standard alcohol units for men and 1 stand alcohol unit for women per day. HCPs will remind participants to aware their drinking portion, in order to quit smoke successfully.
Receives: Behavioral: Standard Smoke Cessation Service; Behavioral: Short Advice for Control Group

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of Participants with Self-reported Tobacco Abstinence in Past 7 Days

    Number of Participants with Self-reported Tobacco Abstinence in Past 7 Days

    Measured: At 2 month follow-up.

  2. Biochemically Validated tobacco abstinence at 2 month follow-up

    Participants who report tobacco abstinence will be invited for a biochemical validation which defined participants as validated quitters if his/her exhaled carbon monoxide is 4ppm or below with a Bedfont Smokerlyzer or 30ng/ml below with the iScreen Oral Fluid Device (OFD) Cotinine Saliva Test Kit.

    Measured: At 2 month follow-up.

  3. Alcohol consumption (alcohol units) in past week;

    The alcohol consumption (alcohol units) in past week;

    Measured: At 2 month follow-up.

  4. AUDIT score

    The AUDIT score will be measured via the AUDIT questionnaire

    Measured: At 2 month follow-up.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Jun 2022
  2. Study start17 Jun 2022
  3. Primary completion31 Oct 2022
  4. Study completion31 Oct 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
A 2-arm, parallel, single-blinded pilot randomized controlled trial to examine the feasibility, acceptability and potential efficacy of implementing the brief alcohol intervention in co-users of tobacco and alcohol.
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
100 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05430529
Sponsor's protocol ID
HKU_alcoholcontrol_protocol_v1
Status last verified
Mar 2023
First submitted
16 Jun 2022
Last updated
23 Mar 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Falk DE, Yi HY, Hiller-Sturmhofel S. An epidemiologic analysis of co-occurring alcohol and tobacco use and disorders: findings from the National Epidemiologic Survey on Alcohol and Related Conditions. Alcohol Res Health. 2006;29(3):162-71.

    PubMed 17373404
  • World Health Organization. AUDIT: The alcohol use disorders identification test: Guidelines for use in primary health care. World Health Organization; 2001.

  • Hart CL, Davey Smith G, Gruer L, Watt GC. The combined effect of smoking tobacco and drinking alcohol on cause-specific mortality: a 30 year cohort study. BMC Public Health. 2010 Dec 24;10:789. doi: 10.1186/1471-2458-10-789.

    PubMed 21184680
  • The Lancet. Tobacco elimination: an economic and public health imperative. Lancet. 2017 Jan 21;389(10066):225. doi: 10.1016/S0140-6736(17)30132-0. Epub 2017 Jan 20. No abstract available.

    PubMed 28118898
  • Rose JE, Brauer LH, Behm FM, Cramblett M, Calkins K, Lawhon D. Potentiation of nicotine reward by alcohol. Alcohol Clin Exp Res. 2002 Dec;26(12):1930-1. doi: 10.1097/01.ALC.0000040982.92057.52. No abstract available.

    PubMed 12500124
  • Cook JW, Fucito LM, Piasecki TM, Piper ME, Schlam TR, Berg KM, Baker TB. Relations of alcohol consumption with smoking cessation milestones and tobacco dependence. J Consult Clin Psychol. 2012 Dec;80(6):1075-85. doi: 10.1037/a0029931. Epub 2012 Sep 10.

    PubMed 22963593
  • Rohsenow DJ, Monti PM, Colby SM, Gulliver SB, Sirota AD, Niaura RS, Abrams DB. Effects of alcohol cues on smoking urges and topography among alcoholic men. Alcohol Clin Exp Res. 1997 Feb;21(1):101-7.

    PubMed 9046380
  • Sayette MA, Martin CS, Wertz JM, Perrott MA, Peters AR. The effects of alcohol on cigarette craving in heavy smokers and tobacco chippers. Psychol Addict Behav. 2005 Sep;19(3):263-70. doi: 10.1037/0893-164X.19.3.263.

    PubMed 16187804
  • Fraser D, Kobinsky K, Smith SS, Kramer J, Theobald WE, Baker TB. Five population-based interventions for smoking cessation: a MOST trial. Transl Behav Med. 2014 Dec;4(4):382-90. doi: 10.1007/s13142-014-0278-8.

    PubMed 25584087
  • Leeman RF, McKee SA, Toll BA, Krishnan-Sarin S, Cooney JL, Makuch RW, O'Malley SS. Risk factors for treatment failure in smokers: relationship to alcohol use and to lifetime history of an alcohol use disorder. Nicotine Tob Res. 2008 Dec;10(12):1793-809. doi: 10.1080/14622200802443742.

    PubMed 19023831
  • Joseph AM, Nelson DB, Nugent SM, Willenbring ML. Timing of alcohol and smoking cessation (TASC): smoking among substance use patients screened and enrolled in a clinical trial. J Addict Dis. 2003;22(4):87-107. doi: 10.1300/j069v22n04_08.

    PubMed 14723480
  • Yardley MM, Mirbaba MM, Ray LA. Pharmacological Options for Smoking Cessation in Heavy-Drinking Smokers. CNS Drugs. 2015;29(10):833-45. doi: 10.1007/s40263-015-0284-5.

    PubMed 26507831
  • Beyer FR, Campbell F, Bertholet N, Daeppen JB, Saunders JB, Pienaar ED, Muirhead CR, Kaner EFS. The Cochrane 2018 Review on Brief Interventions in Primary Care for Hazardous and Harmful Alcohol Consumption: A Distillation for Clinicians and Policy Makers. Alcohol Alcohol. 2019 Jul 1;54(4):417-427. doi: 10.1093/alcalc/agz035.

    PubMed 31062859
  • Kahler CW, Metrik J, LaChance HR, Ramsey SE, Abrams DB, Monti PM, Brown RA. Addressing heavy drinking in smoking cessation treatment: a randomized clinical trial. J Consult Clin Psychol. 2008 Oct;76(5):852-62. doi: 10.1037/a0012717.

    PubMed 18837602
  • Toll BA, Martino S, O'Malley SS, Fucito LM, McKee SA, Kahler CW, Rojewski AM, Mahoney MC, Wu R, Celestino P, Seshadri S, Koutsky J, Hyland A, Cummings KM. A randomized trial for hazardous drinking and smoking cessation for callers to a quitline. J Consult Clin Psychol. 2015 Jun;83(3):445-54. doi: 10.1037/a0038183. Epub 2014 Nov 24.

    PubMed 25419583

Questions about this trial

What is this clinical trial studying?

A study testing Standard Smoke Cessation Service and Brief Alcohol Intervention for Intervention Group in people with Smoking Cessation, run by The University of Hong Kong at 1 site in Hong Kong.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 15 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 23 Mar 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Hong Kong. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number of Participants with Self-reported Tobacco Abstinence in Past 7 Days (time frame: At 2 month follow-up.). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05430529, which also lists 25 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Mar 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in